MicroRNA-146a rs2910164 is associated with severe preeclampsia in Black South African women on HAART

[1]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[2]  C. Tayade,et al.  Evidence of inflammation and predisposition toward metabolic syndrome after pre-eclampsia. , 2015, Pregnancy hypertension.

[3]  C. Labbaye,et al.  miR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4(+) T lymphocytes. , 2015, Virology.

[4]  S. Fawcus,et al.  Maternal death and caesarean section in South Africa: Results from the 2011-2013 Saving Mothers Report of the National Committee for Confidential Enquiries into Maternal Deaths. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[5]  Walter J. Lukiw,et al.  Induction of the pro-inflammatory NF-kB-sensitive miRNA-146a by human neurotrophic viruses , 2015, Front. Microbiol..

[6]  A. Shennan,et al.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.

[7]  You Li,et al.  Genetic Association of MiR-146a with Multiple Sclerosis Susceptibility in the Chinese Population , 2015, Cellular Physiology and Biochemistry.

[8]  S. Booth,et al.  MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response , 2014, Front. Immunol..

[9]  A. Tranquilli.  Early and late-onset pre-eclampsia. , 2014, Pregnancy hypertension.

[10]  James M. Roberts,et al.  Hypertension in Pregnancy: Executive Summary , 2013 .

[11]  R. Raghupathy.  Cytokines as Key Players in the Pathophysiology of Preeclampsia , 2013, Medical Principles and Practice.

[12]  C. Ronsmans,et al.  The contribution of HIV to pregnancy-related mortality: a systematic review and meta-analysis , 2013, AIDS.

[13]  H. Le,et al.  MicroRNA regulation and its effects on cellular transcriptome in Human Immunodeficiency Virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts , 2013, BMC Infectious Diseases.

[14]  Dong-bao Chen,et al.  Human Placental MicroRNAs and Preeclampsia1 , 2013, Biology of reproduction.

[15]  N. Davies.  Fixed-dose combination for adults accessing antiretroviral therapy : advice document , 2013 .

[16]  V. Garovic,et al.  Preeclampsia and the Future Risk of Hypertension: The Pregnant Evidence , 2013, Current Hypertension Reports.

[17]  I. Rebelo,et al.  Inflammatory Disturbances in Preeclampsia: Relationship between Maternal and Umbilical Cord Blood , 2012, Journal of pregnancy.

[18]  J. H. van de Wijgert,et al.  HIV Incidence Remains High in KwaZulu-Natal, South Africa: Evidence from Three Districts , 2012, PloS one.

[19]  B. Sibai,et al.  Maternal mortality from preeclampsia/eclampsia. , 2012, Seminars in perinatology.

[20]  L. Truedsson,et al.  Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene , 2012, Genes and Immunity.

[21]  S. Egginton,et al.  Advances in the cellular and molecular biology of angiogenesis. , 2011, Biochemical Society transactions.

[22]  Asif Ahmed,et al.  Is inflammation the cause of pre-eclampsia? , 2011, Biochemical Society transactions.

[23]  B. Vásárhelyi,et al.  Increased Prevalence of IL‐17‐Producing Peripheral Blood Lymphocytes in Pre‐eclampsia , 2011, American journal of reproductive immunology.

[24]  F. Broughton Pipkin,et al.  The genetics of pre-eclampsia and other hypertensive disorders of pregnancy , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[25]  R. Asmar,et al.  Pre-eclampsia: pathophysiology, diagnosis, and management , 2011, Vascular health and risk management.

[26]  R. Foà,et al.  MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias , 2011, Blood cancer journal.

[27]  K. Mimori,et al.  Clinical Significance of miR-146a in Gastric Cancer Cases , 2011, Clinical Cancer Research.

[28]  L. Cordero,et al.  Maternal Preeclampsia and Neonatal Outcomes , 2011, Journal of pregnancy.

[29]  P. Bugert,et al.  A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk , 2010, Breast Cancer Research and Treatment.

[30]  S. Hébert,et al.  miRNAs in Neurodegeneration , 2007, Science.

[31]  M. Clerici,et al.  Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women. , 2006, Journal of reproductive immunology.

[32]  J. Ernerudh,et al.  Cytokine mapping of sera from women with preeclampsia and normal pregnancies. , 2006, Journal of reproductive immunology.

[33]  J. Moodley,et al.  A Review of the Management of Eclampsia: Practical Issues , 2006, Hypertension in pregnancy.

[34]  J. Pell,et al.  Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.

[35]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[36]  E. Rey,et al.  The prognosis of pregnancy in women with chronic hypertension. , 1994, American journal of obstetrics and gynecology.

[37]  R. Mittendorf.  Risk factors for severe preeclampsia. , 1994, Obstetrics and gynecology.

[38]  B. Sibai,et al.  Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. , 1991, American journal of obstetrics and gynecology.

[39]  N. Mesbah,et al.  Association of MicroRNA-146a rs2910164 Gene Polymorphism with Metabolic Syndrome. , 2015, Folia biologica.

[40]  B. Avcı,et al.  Comparison of maternal serum levels of interleukin-10, interleukin-12, and interleukin-2 in normal and preeclamptic pregnancies. , 2012, Pregnancy hypertension.

[41]  B. Cai,et al.  Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population. , 2012, Human immunology.

[42]  Dilip R Patil,et al.  Recent Advances In Management Of Pre-Eclampsia , 2011 .

[43]  P. Shaikh.  Cytokines & their physiologic and pharmacologic functions in inflammation: A review , 2011 .